Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages

x

This content is available also in other languages


Tecan Journal

Selected category: ELISA kit

Back to overview

Salivary stress biomarkers to nose out the benefits of healthcare clowning to children with psychiatric disorders

Several studies have shown that healthcare clowning has a strong positive effect on pediatric patients in general, but there is limited research into its impact on those with psychological disorders. RED NOSES Clowndoctors Austria – an organization with decades of experience in healthcare clowning – is addressing this issue through a collaboration with the Department of Clinical and Health Psychology at the University of Vienna. A joint study is currently being conducted in several psychiatric in-patient wards across Austria, using salivary stress biomarkers to assess whether clown visits are really benefitting patients.

Read more

Improving speed and accuracy of biomanufacturing for more rapid and cost-effective therapies

The biomanufacturing industry is constantly on the lookout for new technologies to improve the speed, accuracy and performance of its processes, particularly in the biologics arena. Biotechnology company ValitaCell has embraced this challenge, developing novel assays and label-free bright field imaging approaches employing artificial intelligence to complement fluorescence-based cell monitoring techniques.

Read more

A voyage of discovery: exploring the role of HMGB1 in trauma pathology

Trauma is the main cause of premature death internationally, resulting in more deaths in people under 40 years old than all other causes combined. Even trauma victims receiving hospital care have a high mortality rate, in part due to massive systemic inflammatory reactions leading to the dysfunction of organs that were not initially injured. A team at Oslo University Hospital in Norway has been investigating the role of the protein HMGB1 (High Mobility Group Box 1) in the development of trauma pathologies and its potential as a clinical biomarker or therapeutic target in these cases.

Read more
empty cart | close cart
Your cart

Your cart is empty.

Get a quote close form